Differential role of peroxiredoxin II (PrxII) on the expression of toll-like receptor 4 (TLR4) and B-cell activating factor (BAFF) in ovalbumin (OVA)-induced mouse asthma

International Immunopharmacology

Volumn 8, Issue 6, 2008, Pages 935-944

  Moon, Eun Yi ^a,b   Kang, Jong Soon ^b   Han, Seung Hyun ^c   Yang, Kyu Hwan ^d   Pyo, Suhkneung ^e   Lee, Mi Young ^b   Lee, Hyung Kyu ^b   Yu, Dae Yeul ^b  

^a Sejong University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Seoul National University   (South Korea)

^d Gachon University College of Medicine   (South Korea)

^e Sungkyunkwan University   (South Korea)

Author keywords

Asthma; BAFF; PrxII; ROS; TLR4

Indexed keywords

B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN E; MESSENGER RNA; OVALBUMIN; PEROXIREDOXIN; PEROXIREDOXIN II; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR 4;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CELL COUNT; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; EOSINOPHIL; FEMALE; FIBROBLAST; HYPERSENSITIVITY; MALE; MOUSE; MUCUS SECRETION; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; THICKNESS; UPREGULATION; WILD TYPE;

ANIMALS; ASTHMA; B-CELL ACTIVATING FACTOR; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE MODELS, ANIMAL; FIBROBLASTS; MACROPHAGES, PERITONEAL; MICE; MICE, MUTANT STRAINS; OVALBUMIN; PEROXIREDOXINS; REACTIVE OXYGEN SPECIES; SPLEEN; TOLL-LIKE RECEPTOR 4;

EID: 43049105356     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.01.022     Document Type: Article

References (37)

1. Geha R.S., Jabara H.H., and Brodeur S.R. The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 3 9 (2003) 721-732
2. El Biaze M., Boniface S., Koscher V., Mamessier E., Dupuy P., Milhe F., et al. T cell activation, from atopy to asthma: more a paradox than a paradigm. Allergy 58 9 (2003) 844-853
3. Lee K.S., Park H.S., Park S.J., Kim S.R., Min K.H., Jin S.M., et al. An antioxidant modulates expression of receptor activator of NF-kappaB in asthma. Exp Mol Med 38 3 (2006) 217-229
4. Lee K.S., Park H.S., Park S.J., Kim S.R., Min K.H., Jin S.M., et al. A prodrug of cysteine, l-2-oxothiazolidine-4-carboxylic acid, regulates vascular permeability by reducing vascular endothelial growth factor expression in asthma. Mol Pharmacol 68 5 (2005) 1281-1290
5. Lee Y.C., Lee K.S., Park S.J., Park H.S., Lim J.S., Park K.H., et al. Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, l-2-oxothiazolidine-4-carboxylic acid. Faseb J 18 15 (2004) 1917-1919
6. Mackay F., Schneider P., Rennert P., and Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21 (2003) 231-264
7. Mak T.W., and Yeh W.C. Signaling for survival and apoptosis in the immune system. Arthritis Res 4 Suppl 3 (2002) S243-S252
8. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293 5537 (2001) 2111-2114
9. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189 11 (1999) 1747-1756
10. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190 11 (1999) 1697-1710
11. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3 9 (2002) 822-829
12. Rackeman F.M. A working classification of asthma. Am J Med 33 (1947) 601-606
13. Ostergaard P.A. Non-IgE-mediated asthma in children. Acta Paediatr Scand 74 5 (1985) 713-719
14. Corrigan C. Mechanisms of intrinsic asthma. Curr Opin Allergy Clin Immunol 4 1 (2004) 53-56
15. Moon E.Y., Lee J.H., Oh S.Y., Ryu S.K., Kim H.M., Kwak H.S., et al. Reactive oxygen species augment B-cell-activating factor expression. Free Radic Biol Med 40 12 (2006) 2103-2111
16. Han Y.H., Kim H.S., Kim J.M., Kim S.K., Yu D.Y., and Moon E.Y. Inhibitory role of peroxiredoxin II (Prx II) on cellular senescence. FEBS Lett 579 21 (2005) 4897-4902
17. Han Y.H., Kwon J.H., Yu D.Y., and Moon E.Y. Inhibitory effect of peroxiredoxin II (Prx II) on Ras-ERK-NFkappaB pathway in mouse embryonic fibroblast (MEF) senescence. Free Radic Res 40 11 (2006) 1182-1189
18. Moon E.Y., Han Y.H., Lee D.S., Han Y.M., and Yu D.Y. Reactive oxygen species induced by the deletion of peroxiredoxin II (PrxII) increases the number of thymocytes resulting in the enlargement of PrxII-null thymus. Eur J Immunol 34 8 (2004) 2119-2128
19. Moon E.Y., and Ryu S.K. TACI:Fc scavenging B cell activating factor (BAFF) alleviates ovalbumin-induced bronchial asthma in mice. Exp Mol Med 39 3 (2007) 343-352
20. Asehnoune K., Strassheim D., Mitra S., Kim J.Y., and Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 172 4 (2004) 2522-2529
21. Sanlioglu S., Williams C.M., Samavati L., Butler N.S., Wang G., McCray Jr. P.B., et al. Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem 276 32 (2001) 30188-30198
22. Kang J.S., Yoon Y.D., Ahn J.H., Kim S.C., Kim K.H., Kim H.M., et al. B cell-activating factor is a novel diagnosis parameter for asthma. Int Arch Allergy Immunol 141 2 (2006) 181-188
23. Hollingsworth II J.W., Cook D.N., Brass D.M., Walker J.K., Morgan D.L., Foster W.M., et al. The role of Toll-like receptor 4 in environmental airway injury in mice. Am J Respir Crit Care Med 170 2 (2004) 126-132
24. Hollingsworth J.W., Whitehead G.S., Lin K.L., Nakano H., Gunn M.D., Schwartz D.A., et al. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 176 10 (2006) 5856-5862
25. Moon E.Y., and Park H. B cell activating factor (BAFF) gene promoter activity depends upon co-activator, p300. Immunobiology 212 8 (2007) 637-645
26. Moon E.Y., Noh Y.W., Han Y.H., Kim S.U., Kim J.M., Yu D.Y., et al. T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene. Immunol Lett 102 2 (2005) 184-190
27. Yang C.S., Lee D.S., Song C.H., An S.J., Li S., Kim J.M., et al. Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock. J Exp Med 204 (2007) 583-594
28. Nigo Y.I., Yamashita M., Hirahara K., Shinnakasu R., Inami M., Kimura M., et al. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc Natl Acad Sci U S A 103 7 (2006) 2286-2291
29. Kato A., Truong-Tran A.Q., Scott A.L., Matsumoto K., and Schleimer R.P. Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol 177 10 (2006) 7164-7172
30. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12 (1994) 141-179
31. Flohe L., Brigelius-Flohe R., Saliou C., Traber M.G., and Packer L. Redox regulation of NF-kappa B activation. Free Radic Biol Med 22 6 (1997) 1115-1126
32. Toledano M.B., and Leonard W.J. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A 88 10 (1991) 4328-4332
33. Zhang H., Spapen H., Nguyen D.N., Benlabed M., Buurman W.A., and Vincent J.L. Protective effects of N-acetyl-l-cysteine in endotoxemia. Am J Physiol 266 5 Pt 2 (1994) H1746-H1754
34. Dhar A., Young M.R., and Colburn N.H. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol Cell Biochem 234-235 1-2 (2002) 185-193
35. Fu L., Lin-Lee Y.C., Pham L.V., Tamayo A., Yoshimura L., and Ford R.J. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood 107 11 (2006) 4540-4548
36. Tai Y.T., Li X.F., Breitkreutz I., Song W., Neri P., Catley L., et al. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment. Cancer Res 66 13 (2006) 6675-6682
37. Ishida I., Kubo H., Suzuki S., Suzuki T., Akashi S., Inoue K., et al. Hypoxia diminishes toll-like receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells. J Immunol 169 4 (2002) 2069-2075